Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartphone program aims to lighten caregiver burden

NCT ID NCT06785857

First seen Dec 23, 2025 · Last updated Jun 23, 2026 · Updated 26 times

Summary

This study tested a mobile health program designed to support family caregivers of people with both dementia and diabetes. Sixty caregivers received either standard care or the program, which added weekly online support and resources via a smartphone app. The goal was to see if the program could reduce caregiver burden and improve social support.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Community Health Center

    Xiamen, Fujian, 361000, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mHealth Supportive Care Program

What this could lead to

If it works, this could provide a low-cost, convenient way to support family caregivers, reducing their stress and improving care quality.

What could go wrong

This is a small, completed trial with only 60 participants, so results may not apply to all caregivers. The program relies on smartphone access and proficiency, which may limit who can benefit.

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.